We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TXN icon
51
Texas Instruments
TXN
$259B
$26.3M 0.27%
135,278
-23,486
-15% -$4.34M
2020 Q2
16 quarters
PGR icon
52
Progressive
PGR
$126B
$26.3M 0.27%
126,420
-6,232
-5% -$1.3M
2020 Q2
16 quarters
VZ icon
53
Verizon
VZ
$173B
$26.2M 0.27%
635,058
+153
+0% +$6.17K
2020 Q2
16 quarters
DIS icon
54
Walt Disney
DIS
$187B
$25.9M 0.26%
260,587
-5,238
-2% -$564K
2020 Q2
16 quarters
ABT icon
55
Abbott
ABT
$172B
$24.9M 0.25%
239,511
-11,115
-4% -$1.18M
2020 Q2
16 quarters
PFE icon
56
Pfizer
PFE
$161B
$24.9M 0.25%
888,632
-50,202
-5% -$1.38M
2020 Q2
16 quarters
PANW icon
57
Palo Alto Networks
PANW
$343B
$24.6M 0.25%
145,230
+2,308
+2% +$345K
2020 Q2
16 quarters
TJX icon
58
TJX Companies
TJX
$153B
$24.5M 0.25%
222,616
-48,565
-18% -$4.89M
2020 Q2
16 quarters
CDNS icon
59
Cadence Design Systems
CDNS
$97.2B
$24.1M 0.25%
78,468
+4,421
+6% +$1.31M
2020 Q2
16 quarters
DHR icon
60
Danaher
DHR
$155B
$24M 0.25%
96,194
-876
-0.9% -$221K
2020 Q2
16 quarters
GS icon
61
Goldman Sachs
GS
$261B
$23.9M 0.24%
52,845
-796
-1% -$349K
2020 Q2
16 quarters
ELV icon
62
Elevance Health
ELV
$89.5B
$23.8M 0.24%
44,012
-168
-0.4% -$88.8K
2020 Q2
16 quarters
SNPS icon
63
Synopsys
SNPS
$97.7B
$23.8M 0.24%
39,990
+396
+1% +$224K
2020 Q2
16 quarters
CAT icon
64
Caterpillar
CAT
$368B
$23.3M 0.24%
69,862
-30,958
-31% -$10.7M
2020 Q2
16 quarters
AXP icon
65
American Express
AXP
$208B
$23.2M 0.24%
100,194
+686
+0.7% +$159K
2020 Q2
16 quarters
ADP icon
66
Automatic Data Processing
ADP
$107B
$22.9M 0.23%
95,896
+1,942
+2% +$477K
2020 Q2
16 quarters
VRTX icon
67
Vertex Pharmaceuticals
VRTX
$129B
$22.4M 0.23%
47,695
-11,371
-19% -$4.94M
2020 Q2
16 quarters
IBM icon
68
IBM
IBM
$214B
$22.2M 0.23%
128,385
-694
-0.5% -$121K
2020 Q2
16 quarters
AMT icon
69
American Tower
AMT
$84.9B
$22.2M 0.23%
113,981
-1,058
-0.9% -$198K
2020 Q2
16 quarters
ANET icon
70
Arista Networks
ANET
$273B
$22.1M 0.23%
251,860
+19,440
+8% +$1.45M
2020 Q2
16 quarters
MRSH icon
71
Marsh
MRSH
$83.9B
$22M 0.22%
104,208
-31,711
-23% -$6.51M
2020 Q2
16 quarters
MCO icon
72
Moody's
MCO
$80.4B
$21.9M 0.22%
51,989
+905
+2% +$360K
2020 Q2
16 quarters
CMCSA icon
73
Comcast
CMCSA
$73.3B
$21M 0.22%
537,406
-9,967
-2% -$390K
2020 Q2
16 quarters
SBUX icon
74
Starbucks
SBUX
$103B
$20.6M 0.21%
264,970
+1,735
+0.7% +$141K
2020 Q2
16 quarters
MU icon
75
Micron Technology
MU
$1.16T
$20.5M 0.21%
156,197
+427
+0.3% +$53.8K
2020 Q2
16 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.